Nephrocare Health Services Limited (NSE:NEPHROPLUS)

Market Cap	58.38B
Revenue (ttm)	9.52B +117.8%
Net Income	713.37M
EPS	7.90
Shares Out	100.34M
PE Ratio	73.68
Forward PE	39.45
Dividend	n/a
Ex-Dividend Date	n/a

Volume	49,294
Average Volume	263,765
Open	588.00
Previous Close	588.10
Day's Range	577.20 - 589.45
52-Week Range	446.00 - 603.80
Beta	n/a
RSI	66.76
Earnings Date	Feb 10, 2026

About NSE:NEPHROPLUS

Nephrocare Health Services Limited operates a chain of kidney care clinics that provides dialysis healthcare services with dialysis centres in India, Uzbekistan, Nepal, Kingdom of Saudi Arabia, and the Philippines. It provides In-clinic dialysis, dialysis on call, home hemodialysis, holiday dialysis, and dialysis on wheels services. Nephrocare Health Services Limited was incorporated in 2009 and is based in Hyderabad, India.

• Industry: Miscellaneous Health And Allied Services, Not Elsewhere Classified
• Founded: 2009
• Employees: 3,448
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: NEPHROPLUS

Financial Performance

In fiscal year 2025, NSE:NEPHROPLUS's revenue was 7.56 billion, an increase of 33.50% compared to the previous year's 5.66 billion. Earnings were 670.96 million, an increase of 90.98%.